ProText Mobility Inc (TXTM)

[stervc]

TXTM/PLPL, Sunkist, USDA, & CDXC:NASDAQ Connection

The research that was previously posted by JPS02 adds to the ”validity” of what we have here with TXTM (PLPL). In my opinion, TXTM is like a OWCP, SGBY, and CGRW all wrapped up into one. The key with TXTM is that they already have the infrastructure in place to do marijuana cultivation, marijuana laboratory, marijuana clinical trials, medical marijuana, etc. because of PLPL being their Parent Company controlling them.

These are some huge agencies and companies that you posted from their website of which they had previously conducted Clinical Trials with of which these Clinical Trials were very successful. Below are the results from the Clinical Trials that were conducted with Sunkist, USDA, and ChromaDex (CDXC:NASDAQ) for those who have not learned of this yet to confirm the legitimacy of the company:

http://plandaibiotech.com/research-development.html
A total of forty six patients (74.2%) reported on the second day of taking the medication that they achieved complete or substantial relief when taking the bioflavonoid combination. In comparison only 30% (50.9%) taking ACP’s, the best known palliative obtained similar relief.

Sunkist is a company that I think we all are familiar with that has generated over $1 Billion in Revenues for 6 (six) consecutive years:
https://www.sunkist.com/press-room/sunkist-growers-announces-sixth-straight-billion-dollar-revenue-year-and-second-consecutive-billion-dollar-grower-payment/

https://www.sunkist.com/



ChromaDex trades on the NASDAQ at over $2.80+ per share with an over $109 Million Market Cap:
https://www.chromadex.com/



United States Department of Agriculture (USDA):
https://www.usda.gov/wps/portal/usda/usdahome

PLPL
https://www.otcmarkets.com/stock/PLPL/profile
http://www.plandaibiotech.com/

TXTM
https://www.otcmarkets.com/stock/TXTM/profile
http://www.protextm.co/

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128001478

http://www.plandaibiotech.com/president.html
"With respect to cannabis, we’ve completed the bulk of our science and are now aggressively seeking a legal venue for producingour Phytofare™ Cannabinoid complex and getting it into clinical trials"

http://www.plandaibiotech.com/cannabis.html
...With that being said, Plandaí believes that cannabis shows great medical potential. Unfortunately, very little testing has been done in a true, double-blind, controlled human clinical environment. Much of what we know is either anecdotal or backed by small lab-scale studies. We have developed the science that will allow us to produce a highly bioavailable cannabinoid complex. This new product should enable us to deliver a clinical dose of cannabinoids directly to human tissue and, theoretically, even cross the blood-brain barrier, enabling us to treat neuron disorders. ...

...Plandaí is actively working with several government agencies in hopes of being granted permission to commence testing our cannabinoid product. Once this permission is received, it will take us about ninety days to set up an extraction lab and produce the first extract. This extract will then be tested for purity and undergo a full chemical profile. ...

...We believe that favorable clinical trials will eventually pave the way for government acceptance. Especially for products like Plandaí’s which will have no psychoactive effects. Once we reach that point, we will have several decisions to make: Do we produce an extract locally? Do we license the technology to a third party? Do we farm our own product or purchase from a local grower? ...

...The takeaway for our investors is that Plandaí remains committed to conducting ongoing research with a variety of different plants including cannabis and that this research will go forward as fast as the legal climate permits. Until such time, we remain committed to obeying the laws—federal, state, and international—while we continue to champion for changes to those laws and establish industry standards. We have a fiduciary responsibility to our shareholders to ensure that our company is built on a solid foundation of science, ethics, frugality, and adherence to the laws of the land. ...

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128025299

ARTIST, with this Huge TXTM/PLPL South Africa Endorsement

TXTM is an investment that is being setup to help an entire country (South Africa). The market is a little slow in seeing it right now, but I think as more is confirmed and learned by more investors, they will see the magnitude of what's being built here. All should read this 8-K below of the Share Exchange Agreement that closed the TXTM acquisition of Plandaí Biotechnology South Africa:
http://ih.advfn.com/p.php?pid=nmona&article=73652133

This is huge in my opinion regarding Plandai Biotechnology (PLPL) since the TXTM portion of the company that is now Plandaí Biotechnology South Africa will be the vehicle used for the Cannabis/Marijuana projects in South Africa.

What you posted below will tie in very well with South Africa legalizing marijuana this coming Feb 2017:

Plandai Biotechnology, Inc. Announces South African Department of Health Endorses Access to Medicinal Cannabis / Move may provide an opportunity for Plandai's research to move forward in South Africa
http://www.finanznachrichten.de/nachrichten-2016-12/39399286-plandai-biotechnology-inc-announces-south-african-department-of-health-endorses-access-to-medicinal-cannabis-move-may-provide-an-opportunity-for-p-256.htm

http://www.health.gov.za/

http://www.gov.za/welcome-official-government-online-site

v/r
Sterling

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128031986

mymonies, with these significant TXTM thoughts…

I agree with your thoughts. Doing it this way allows for PLPL to not lose or be hit if things don’t work out because TXTM will eventually be judged on its own merits whether they sink or swim.

However, if things turn out to be as big as they believe, which is why they went down this path in the first place, then PLPL will gain twice as much since they are the Parent Company for TXTM.

The difference between most of the MJ stocks versus TXTM is that most of the MJ stocks operate with only having the reach from its single regulated state only. Now, with TXTM, they are operationally structured to have the reach for an entire country. The TXTM position for expansion is far greater in my opinion.

v/r
Sterling

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128032014

Key TXTM & PLPL Connecting Variables

Below from the TXTM Investor’s page, the company has very clearly laid out the TXTM & PLPL Connecting Variables:

http://www.protextm.co/investors


v/r
Sterling

v/r
Sterling